Clinical Trial Update: Safety and Efficacy Study of RENEWAL 4 AVT [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 safety and efficacy study of the RENEWAL 4 AVT has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation
• Atrial Flutter
• Heart Failure
• Tachycardia
• Ventricular Fibrillation

Drugs mentioned

• RENEWAL 4 AVT

Snippet

Sponsor: Boston Scientific Corporation | Conditions: Heart Failure, Tachycardia | Phase 2, Phase 3 | Status: COMPLETED